Intra- and interobserver problems in the histopathologic classification of malignant lung tumorsHIRSCH, F. R.Developments in oncology. 1986, Vol 39, pp 53-56, issn 0167-4927Article

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerCHRISTOPH, D. C; KASPER, S; WELTER, S et al.British journal of cancer. 2012, Vol 107, Num 5, pp 823-830, issn 0007-0920, 8 p.Article

Consensus conference on medical treatment of non-small cell lung cancer: Adjuvant treatmentTONATO, Maurizio.Lung cancer. 2002, Vol 38, pp S37-S42, issn 0169-5002, SUP3Article

Combined chemotherapy and radiotherapy in inoperable non-small cell lung cancerJASSEM, Jacek.Lung cancer. 2002, Vol 38, pp S43-S46, issn 0169-5002, SUP3Article

Role of supportive care in the treatment of NSCLC supportive care for myelotoxicityBEINERT, Thomas.Lung cancer. 2002, Vol 38, pp S79-S80, issn 0169-5002, SUP3Article

The role of chemotherapy (CT) and supportive care (SC) in advanced non-small cell lung cancer (NSCLC)THATCHER, Nick.Lung cancer. 2002, Vol 38, pp S71-S73, issn 0169-5002, SUP3Article

Diagnosis of abominal metastases in small cell carcinoma of the lung : A prospective study of computer tomography and ultrasonographyINGEMANN JENSEN, L; HIRSCH, F. R; PETERS, K et al.Lung cancer. 1992, Vol 8, Num 1, pp 37-46, issn 0169-5002Article

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsCAPPUZZO, F; TOSCHI, L; FRANKLIN, W. A et al.British journal of cancer. 2005, Vol 93, Num 12, pp 1334-1340, issn 0007-0920, 7 p.Article

High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancerBREMNES, R. M; VEVE, R; GABRIELSON, E et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2417-2428, issn 0732-183XArticle

European concensus conference on medical treatment of non-small cell lung cancerZIELINSKI, C; KRAINER, M; HIRSCH, F. R et al.Lung cancer. 2002, Vol 38, issn 0169-5002, 87 p., SUP3Serial Issue

Combined platinum containing treatment in NSCLCCRINO, Lucio.Lung cancer. 2002, Vol 38, pp S51-S52, issn 0169-5002, SUP3Article

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma : A prospective randomised trial of 280 consecutive patientsHIRSCH, F. R; ØSTERLIND, K; JEPPESEN, N et al.Annals of oncology. 2001, Vol 12, Num 5, pp 647-653, issn 0923-7534Article

Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancerJOÊRGENSEN, L. G. M; HIRSCH, F. R; SKOV, B. G et al.British journal of cancer. 1991, Vol 63, Num 1, pp 151-153, issn 0007-0920, 3 p.Article

Staging and prognostic factors in small cell lung cancer: a consensus reportSTAHEL, R. A; GINSBERG, R; HAVEMANN, K et al.Lung cancer. 1989, Vol 5, Num 4-6, pp 119-126, issn 0169-5002, 8 p.Conference Paper

The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the world health organization = La signification pronostique de la sous-classification histologique des épithiliomas à petites cellules du poumon en fonction de la classification de l'organisation mondiale de la santé. Une étude de 375 cas consécutifsHIRSCH, F. R; ØSTERLIND, K; HANSEN, H. H et al.Cancer. 1983, Vol 52, Num 11, pp 2144-2150, issn 0008-543XArticle

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomasHIRSCH, F. R; VARELLA-GARCIA, M; FRANKLIN, W. A et al.British journal of cancer. 2002, Vol 86, Num 9, pp 1449-1456, issn 0007-0920Article

Chemotherapy in NSCLC: historical reviewKOSMIDIS, Paris.Lung cancer. 2002, Vol 38, pp S19-S22, issn 0169-5002, SUP3Article

Should maintenance chemotherapy be used to treat small cell lung cancer?SCULIER, J.-P; JOSS, R. A; SCHEFER, H et al.European journal of cancer (1990). 1998, Vol 34, Num 8, pp 1148-1155, issn 0959-8049Article

Neuroendocrine characteristics in bronchogenic adenocarcinoma and its clinical relevanceHIRSCH, F. R; SKOV, B. G.Lung cancer. 1993, Vol 9, Num 1-6, pp 89-96, issn 0169-5002Conference Paper

The role of the pathologist in the clinical management of lung cancer in the 90'sHIRSCH, F. R; RYGAARD, K.Lung cancer. 1993, Vol 9, Num 1-6, pp 111-117, issn 0169-5002Conference Paper

Immunocytochemical demonstration of bombesin immunoreactivity in small-cell carcinoma of the lung: a methodological study and review of the literatureHIRSCH, F. R; HOLST, J. J; SPANG-THOMSEN, M et al.Lung cancer. 1990, Vol 6, Num 1-2, pp 1-8, issn 0169-5002, 8 p.Article

A review of the 5th world congress on lung cancer held by the International Association for the study of lung cancerKRISTJANSEN, P. E. G; HIRSCH, F. R.The European respiratory journal. 1989, Vol 2, Num 3, pp 275-279, issn 0903-1936Article

Histopathologic classification of small cell lung cancer: changing concepts and terminologyHIRSCH, F. R; MATTHEWS, M. J; YESNER, R et al.Cancer. 1988, Vol 62, Num 5, pp 973-977, issn 0008-543XArticle

ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC)WITTA, S. E; DZIADZIUSZKO, R; YOSHIDA, K et al.Annals of oncology. 2009, Vol 20, Num 4, pp 689-695, issn 0923-7534, 7 p.Article

Page / 3